Completed NA INTERVENTIONAL NCT01550549

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Sponsor: Avid Radiopharmaceuticals

Conditions Alzheimer Disease Mild Cognitive Impairment Neurodegenerative Diseases

Updated 8 times since 2017 Last updated: May 3, 2012 Started: Aug 31, 2011 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01550549, this NA trial focuses on Alzheimer Disease and Mild Cognitive Impairment and remains completed. Sponsored by Avid Radiopharmaceuticals, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Avid Radiopharmaceuticals

Data source: Avid Radiopharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.